Have your own idea? Try our Stock Screener
Israeli (TA) Biotech Industry Analysis
UpdatedSep 26, 2025
DataAggregated Company Financials
Companies13
- 7D-2.9%
- 3M-9.7%
- 1Y-12.1%
- YTD-4.8%
Last week, the Biotech industry hasn't moved much but Kadimastem is up 5.5% in that time. As for the longer term, the industry has declined 10.0% in the last year. Looking forward, earnings are forecast to grow by 20% annually.
Industry Valuation and Performance
Has the Israeli Biotech Industry valuation changed over the past few years?
| Date | Market Cap | Revenue | Earnings | PE | Absolute PE | PS |
|---|---|---|---|---|---|---|
| Fri, 26 Sep 2025 | ₪2.1b | ₪664.9m | -₪100,020,262.00 | 12.4x | -20.7x | 3.1x |
| Sun, 24 Aug 2025 | ₪2.2b | ₪669.6m | -₪133,066,649.70 | 13.3x | -16.2x | 3.2x |
| Tue, 22 Jul 2025 | ₪2.3b | ₪664.8m | -₪128,491,122.60 | 16.5x | -17.8x | 3.4x |
| Thu, 19 Jun 2025 | ₪2.2b | ₪692.0m | -₪130,064,764.80 | 15.3x | -16.8x | 3.2x |
| Sat, 17 May 2025 | ₪2.2b | ₪735.7m | -₪156,101,545.60 | 14.8x | -14.2x | 3x |
| Mon, 14 Apr 2025 | ₪2.0b | ₪750.2m | -₪163,015,976.20 | 14.6x | -12.5x | 2.7x |
| Wed, 12 Mar 2025 | ₪2.2b | ₪706.4m | -₪225,160,684.80 | 16.8x | -9.9x | 3.2x |
| Fri, 07 Feb 2025 | ₪2.2b | ₪675.3m | -₪226,692,581.80 | 15.3x | -9.7x | 3.2x |
| Sun, 05 Jan 2025 | ₪2.1b | ₪692.6m | -₪230,010,784.60 | 14.4x | -9x | 3x |
| Tue, 03 Dec 2024 | ₪2.0b | ₪693.4m | -₪227,723,840.40 | 13.5x | -8.7x | 2.9x |
| Thu, 31 Oct 2024 | ₪2.0b | ₪678.8m | -₪256,106,409.50 | 13.5x | -7.8x | 2.9x |
| Sat, 28 Sep 2024 | ₪2.1b | ₪682.9m | -₪257,053,528.10 | 13.1x | -8x | 3x |
| Mon, 26 Aug 2024 | ₪2.2b | ₪674.4m | -₪217,624,503.00 | 13.6x | -10x | 3.2x |
| Wed, 24 Jul 2024 | ₪2.2b | ₪626.8m | -₪324,305,866.80 | 17.4x | -6.8x | 3.5x |
| Fri, 21 Jun 2024 | ₪2.0b | ₪643.7m | -₪330,736,879.70 | 15.4x | -6x | 3.1x |
| Sun, 19 May 2024 | ₪2.1b | ₪598.9m | -₪382,053,327.70 | 16.4x | -5.5x | 3.5x |
| Tue, 16 Apr 2024 | ₪2.1b | ₪617.8m | -₪407,442,389.30 | 21.7x | -5.2x | 3.4x |
| Thu, 14 Mar 2024 | ₪2.3b | ₪545.5m | -₪367,109,193.00 | 54.4x | -6.3x | 4.3x |
| Sat, 10 Feb 2024 | ₪2.3b | ₪585.8m | -₪367,427,738.60 | 62.2x | -6.3x | 3.9x |
| Mon, 08 Jan 2024 | ₪2.4b | ₪629.5m | -₪399,551,706.00 | 62.6x | -6.1x | 3.9x |
| Wed, 06 Dec 2023 | ₪2.2b | ₪636.5m | -₪404,227,866.00 | 57.1x | -5.3x | 3.4x |
| Fri, 03 Nov 2023 | ₪2.1b | ₪642.0m | -₪424,026,944.00 | 72.7x | -5x | 3.3x |
| Sun, 01 Oct 2023 | ₪2.3b | ₪619.8m | -₪409,216,995.00 | 76x | -5.6x | 3.7x |
| Tue, 29 Aug 2023 | ₪1.9b | ₪616.0m | -₪339,512,078.00 | 65.2x | -5.6x | 3.1x |
| Thu, 27 Jul 2023 | ₪1.9b | ₪546.6m | -₪394,565,528.00 | n/a | -4.8x | 3.4x |
| Sat, 24 Jun 2023 | ₪1.9b | ₪538.1m | -₪389,974,817.00 | n/a | -4.9x | 3.6x |
| Mon, 22 May 2023 | ₪1.8b | ₪529.4m | -₪371,506,126.00 | n/a | -4.8x | 3.4x |
| Wed, 19 Apr 2023 | ₪1.7b | ₪607.8m | -₪443,715,160.00 | n/a | -3.8x | 2.8x |
| Fri, 17 Mar 2023 | ₪1.5b | ₪615.8m | -₪436,341,070.00 | 4.4x | -3.5x | 2.5x |
| Sun, 12 Feb 2023 | ₪1.6b | ₪547.6m | -₪471,196,784.00 | 4.6x | -3.4x | 3x |
| Tue, 10 Jan 2023 | ₪1.7b | ₪528.7m | -₪471,850,827.00 | 17.5x | -3.6x | 3.2x |
| Thu, 08 Dec 2022 | ₪1.7b | ₪479.4m | -₪464,909,523.00 | 17.3x | -3.6x | 3.5x |
| Sat, 05 Nov 2022 | ₪1.8b | ₪498.7m | -₪491,047,657.00 | 18.3x | -3.7x | 3.6x |
| Mon, 03 Oct 2022 | ₪1.8b | ₪496.6m | -₪489,517,456.00 | 18.1x | -3.7x | 3.7x |
Price to Earnings Ratio
-3.7x
Current Industry PE
- Investors are relatively neutral on the Israeli Biotechs industry at the moment, indicating that they anticipate long term growth rates to remain steady.
- The industry is trading close to its 3-year average PS ratio of 3.3x.
Past Earnings Growth
- The earnings for companies in the Biotechs industry have improved over the last three years.
- Revenues for these companies have grown 10% per year.
- This means that more sales are being generated by these companies overall, and subsequently losses are decreasing too.
Industry Trends
Which industries have driven the changes within the Israeli Healthcare industry?
| IL Market | -0.89% | |
| Healthcare | -2.19% | |
| Biotech | -2.92% | |
| Biotech | -2.92% | |
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.
Top Stock Gainers and Losers
Which companies have driven the market over the last 7 days?
| Company | Last Price | 7D | 1Y | Valuation | |
|---|---|---|---|---|---|
| KDST Kadimastem | ₪32.00 | 5.5% +₪7.5m | 348.1% | PE-2.3x | |
| NXTG Nextage Therapeutics | ₪0.85 | 9.0% +₪2.4m | 24.8% | PS69.4x | |
| GRAC Grace Breeding | ₪20.00 | 2.2% +₪1.8m | 20.5% | PB46x | |
| XTLB XTL Biopharmaceuticals | ₪0.042 | 2.4% +₪881.4k | -55.3% | PS24.5x |